|本期目录/Table of Contents|

[1]王建福,颜双凤,庄岳鹏,等.血清淀粉样蛋白A、白蛋白水平慢性阻塞性肺疾病急性加重期预后的相关性分析[J].中华肺部疾病杂志,2020,(06):797-800.[doi:10.3877/cma.j.issn.1674-6902.2020.06.019]
点击复制

血清淀粉样蛋白A、白蛋白水平慢性阻塞性肺疾病急性加重期预后的相关性分析(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2020年06期
页码:
797-800
栏目:
短篇论著
出版日期:
2020-12-20

文章信息/Info

Title:
-
作者:
王建福1; 颜双凤2; 庄岳鹏1; 王晓东3
362000 泉州,中国人民解放军联勤保障部队第九一〇医院检验科1、卫勤处2 362100 惠安,中国人民解放军73159部队3
Author(s):
-
关键词:
肺疾病; 慢性阻塞性;  血清淀粉样蛋白A;  白蛋白
Keywords:
-
分类号:
-
DOI:
10.3877/cma.j.issn.1674-6902.2020.06.019
摘要:
-
Abstract:
-

参考文献/References:

1 任成山, 王关嵩, 钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
2 Jiang X, Xiao H, Segal R, et al. Trends in readmission rates, hospital charges, and mortality for patients with chronic obstructive pulmonary disease(COPD)in florida from 2009 to 2014[J]. Clin Ther, 2018, 40(4): 613-626.
3 Kelly AM, Holdgate A, Keijzers G, et al. Epidemiology, treatment, disposition and outcome of patients with acute exacerbation of COPD presenting to emergency departments in Australia and South East Asia: an AANZDEM study[J]. Respirology, 2018, 23(7): 681-686.
4 Duffy S, Marron R, Voelker H, et al. Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease(COPD)[J]. Respir Res, 2017, 18(1): 124-125.
5 李 静, 朱述阳. 血清淀粉样蛋白A对慢性阻塞性肺疾病急性加重期的诊断价值[J]. 中国临床医生杂志, 2017, 45(9): 23-26.
6 Jiang TT, Shi LY, Wei LL, et al. Serum amyloid A, protein Z, and C4b-binding protein β chain as new potential biomarkers for pulmonary tuberculosis[J]. Plos One, 2017, 12(3): e0173304.
7 沈 雅, 韩明锋. 血清白蛋白在慢性阻塞性肺疾病急性加重期患者中的临床意义[J]. 安徽医药, 2018, 22(6): 1126-1129.
8 朱 蕾. 临床肺功能. 第2版[M]. 人民卫生出版社, 2014: 256.
9 慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版)[J]. 国际呼吸杂志, 2017, 37(14): 1041-1057.
10 Johnson AEW, Kramer AA, Clifford GD. A new severity of illness scale using a subset of acute physiology and chronic health evaluation data elements shows comparable predictive accuracy[J]. Crit Care Med, 2013, 41(7): 1711-1718.
11 Jinjuvadia C, Jinjuvadia R, Mandapakala C, et al. Trends in outcomes,financial burden, and mortality for acute exacerbation of chronic obstructive pulmonary disease(COPD)in the United States from 2002 to 2010[J]. COPD, 2017, 14(1): 72-79.
12 沈奕播, 仇 晟, 李 琦. 慢性阻塞性肺疾病急性加重患者预后危险因素分析[J/CD]. 中华肺部疾病杂志(电子版), 2018, 11(3): 344-346.
13 Aiyuan Z, Zijing Z, Yiyang Z, et al. The recent advances of phenotypes in acute exacerbations of COPD[J]. Int J Chron Obstruct Pulmon Dis, 2017, 27(12): 1009-1018.
14 Yanyan L, Linlin X, Shuzhen X, et al. Values of procalcitonin and C-reactive proteins in the diagnosis and treatment of chronic obstructive pulmonary disease having concomitant bacterial infection[J]. Pak J Med Sci, 2017, 33(3): 566-569.
15 唐海成, 柏宏坚. 血清降钙素原与肺部感染评分在慢性阻塞性肺疾病急性加重期患者中的临床意义[J/CD]. 中华肺部疾病杂志(电子版), 2018, 11(2): 216-218.
16 郑全理, 王向伟, 杨飞丹. 慢性阻塞性肺疾病患者外周血降钙素原水平的改变及与肺功能关系的临床研究[J]. 临床肺科杂志, 2017, 22(1): 124-128.
17 Nouvenne A, Ticinesi A, Lauretani F, et al. The prognostic value of high-sensitivity C-reactive protein and prealbumin for short-term mortality in acutely hospitalized multimorbid elderly patients: A prospective cohort study[J]. J Nutr Health Aging, 2016, 20(4): 462-468.
18 赖寿兰, 李巍立, 王卫方, 等. COPD稳定期患者血清前白蛋白白蛋白及血红蛋白水平与BODE指数的关系[J]. 河北医学, 2019, 25(11): 1809-1813.
19 Yarur AJ, Quintero MA, Anjali J, et al. Serum amyloid a as a surrogate marker for mucosal and histologic inflammation in patients with Crohn's disease[J]. Inflamm Bowel Dis, 2017, 23(1): 158-164.
20 Azurmendi L, Lapierre-Fetaud V, Schneider J, et al. Proteomic discovery and verification of serum amyloid A as a predictor marker of patients at risk of post-stroke infection: a pilot study[J]. Clin Proteomics, 2017, 14(1): 27-29.

备注/Memo

备注/Memo:
基金项目: 福建省泉州市科技计划项目资助课题(2012z58)
通信作者: 颜双凤, Email: 541973142@qq.com
更新日期/Last Update: 2020-12-20